Project leads
Collaborators

Prostate Cancer Susceptibility: The ICPCG Study

Stephen N Thibodeau

7 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Fredrik Wiklund

Karolinska Institute

Stockholm, Sweden

William Foulkes

Montreal General Hospital

Montreal, Canada

Jewish General Hospital

Montreal, Canada

McGill University

Montreal, Canada

Rosalind Eeles

Institute of Cancer Research

London, United Kingdom

Johanna Schleutker

University of Turku

Turku, Finland

Graham G Giles

Cancer Council Victoria

Melbourne, Australia

Christiane Maier

University of Ulm

Ulm, Germany

Stephen N Thibodeau

Mayo Clinic (Rochester)

Rochester, United States

Olivier Cussenot

Tenon Hospital

Paris, France

Cerepp

Paris, France

Related projects

Hsian-Rong Tseng

Thermoresponsive Nanovelcro CTC Purification System For Prostate Cancer Profiling

Rosalynd Denise Upton

Elucidating the Molecular Basis of Metastatic Prostate Cancer Cell Progression

James P Quigley

Role of Inflammatory Neutrophils and their Unique MMP-9 in Tumor Progression

Sue-Hwa Lin

Endothelial-to-osteoblast transition in prostate cancer bone metastasis

Ian M Thompson

San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)

Mark A Rubin

Molecular Signatures of Lethal and Indolent Prostate Cancer

Ian M Thompson

San Antonio Center for Biomarkers of Risk For Prostate Cancer (SABOR)

Hyung L Kim

Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer

David Alan Bader

Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer